Understanding DNA Methylation Differences in Cancer by Sex
Author Information
Author(s): Zhou Jiaqi, Li Miao, Chen Yu, Wang Shangzi, Wang Danke, Suo Chen, Chen Xingdong
Primary Institution: Fudan University
Hypothesis
Sex differences in DNA methylation levels are reorganized in cancers, resulting in ubiquitous sex-biased regulation of DNA methylation across cancers.
Conclusion
The study reveals that sex differences in DNA methylation are significantly reduced in cancerous tissues compared to normal tissues, suggesting a more homogeneous epigenetic pattern during cancer progression.
Supporting Evidence
- The analysis identified 3,452 CpGs associated with reduced sex differences in cancerous tissues.
- 72% of the linked genes were involved in X chromosome inactivation.
- Significant correlations were found between DNA methylation and gene expression, indicating a sex-specific regulatory role.
Takeaway
This study looks at how DNA changes in men and women with cancer are different, finding that these differences are less clear in cancer than in normal tissues.
Methodology
The study utilized data from The Cancer Genome Atlas to analyze sex-related DNA methylation effects in nine non-reproductive cancers, comparing cancer tissues with paired normal adjacent tissues.
Potential Biases
Potential biases due to the unequal sample sizes between male and female participants.
Limitations
The study's sample sizes were imbalanced between sexes, which may affect the robustness of the findings.
Participant Demographics
The analysis included 3,435 cancer samples (1,345 females and 2,090 males) and 482 paired normal adjacent samples.
Statistical Information
P-Value
Pbonf<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website